Guided Therapeutics (GTHP) Return on Assets (2012 - 2025)

Guided Therapeutics has disclosed Return on Assets across 14 years of filings, most recently posting 0.03% for Q4 2025.

• Return on Assets for Q4 2025 came in at 0.03%, down 1.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.03% (down 1.0% YoY), and the FY2025 annual result was 0.02%, down 1.0% from the prior year.
• Return on Assets came in at 0.03% for Q4 2025 at Guided Therapeutics, down from 0.03% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q2 2021 to a low of 0.03% in Q4 2025.
• The 5-year median for Return on Assets is 0.02% (2024), against an average of 0.02%.
• Peak annual rise in Return on Assets reached 6 bps in 2021, while the deepest fall reached 3 bps in 2021.
• Guided Therapeutics' Return on Assets stood at 0.01% in 2021, then dropped by 18 bps to 0.01% in 2022, then plunged by 64 bps to 0.02% in 2023, then increased by 6 bps to 0.02% in 2024, then slumped by 56 bps to 0.03% in 2025.
• The last three Return on Assets figures came in at 0.03% (Q4 2025), 0.03% (Q3 2025), and 0.03% (Q2 2025), per Business Quant data.